Spermidine may be one of the missing metabolic links between exercise, autophagy, and healthy muscle aging.
A new review in Mechanisms of Ageing and Development frames skeletal muscle aging as a failure of proteostasis mitochondrial quality control, where impaired autophagy allows damaged mitochondria, ROS, and protein aggregates to accumulate — driving atrophy, weakness, and sarcopenia.
The central axis:
polyamines → spermidine → autophagy → mitochondrial quality control → muscle resilience
Spermidine is a naturally occurring polyamine derived from diet, gut microbiota, endogenous synthesis, and polyamine interconversion. It has emerged as a physiological autophagy inducer, partly by inhibiting EP300-dependent acetylation and promoting autophagy-related programs such as ATG genes, FOXO3 signaling, and eIF5A hypusination.
In skeletal muscle, this matters because autophagy is not simply “catabolism.” It is a quality-control system.
Too little autophagy → damaged mitochondria, oxidative stress, neuromuscular junction degeneration, weakness.
Too much or dysregulated autophagy → atrophy.
The therapeutic goal is not maximal autophagy, but autophagic balance.
The review also highlights SMOX, spermine oxidase, as a key node. SMOX converts spermine into spermidine, potentially sustaining autophagy-related pathways and muscle homeostasis. Healthy muscle maintains SMOX expression, whereas multiple atrophy models — immobilization, fasting, denervation, and aging — show SMOX repression. Lowering SMOX alone can promote fiber atrophy, while forced SMOX expression can enlarge fiber size in atrophic settings.
Exercise enters as the physiological partner.
Muscle contraction creates transient energetic and redox stress — AMP/ATP shift, NAD⁺ increase, ROS pulses, calcium signaling — which activates AMPK, PGC-1α, mitophagy, and autophagy. In aging muscle, exercise may act as a hormetic “wake-up call” that restores stagnant cellular quality-control systems.
The most interesting framing is synergy:
spermidine supplementation exercise may converge on AMPK–FOXO3, AKT/mTOR, mitochondrial turnover, apoptosis reduction, and autophagic balance. In D-galactose aging models, the combined intervention reversed several atrophy-like phenotypes better than either approach alone.
But caution is essential. Spermidine is not universally beneficial. Effects may depend on dose, timing, tissue context, pathology, fibrosis risk, and long-term safety. Clinical translation still needs controlled human trials.
Take-home: muscle aging may be treatable not only by anabolic stimulation, but by restoring the polyamine–autophagy–mitochondria quality-control network.
Skeletal muscle aging may be less about “muscle loss alone” and more about failure of cellular quality control.
A new review highlights a converging axis:
polyamines → spermidine → SMOX → autophagy → mitochondrial quality control → muscle resilience
Autophagy is essential in skeletal muscle because it removes damaged proteins, dysfunctional mitochondria, and stress-induced cellular debris. But aging disrupts this balance. Too little autophagy allows ROS, protein aggregates, and defective mitochondria to accumulate, contributing to sarcopenia and weakness. Too much or dysregulated autophagy can also promote atrophy.
So the target is not “more autophagy.”
The target is autophagic balance.
Spermidine, a natural polyamine, emerges as a key regulator of this system. It can promote autophagy through several mechanisms: inhibition of EP300-mediated acetylation, activation of ATG-related programs, FOXO3 signaling, and eIF5A hypusination. Together, these pathways support proteostasis and mitochondrial renewal.
The review also places spermine oxidase (SMOX) at the center of muscle homeostasis. SMOX converts spermine into spermidine and may help sustain autophagy-related pathways in healthy muscle. Importantly, SMOX expression declines in multiple atrophy settings, including fasting, immobilization, denervation, and aging. This suggests that impaired polyamine turnover may be part of the molecular signature of muscle wasting.
Exercise acts as the physiological partner.
Muscle contraction creates transient energetic and redox stress—AMPK activation, ROS pulses, NAD⁺ shifts, calcium signaling, and PGC-1α induction. These signals stimulate mitophagy, autophagy, and mitochondrial remodeling. In aged muscle, exercise may function as a hormetic “wake-up call” that restores stagnant quality-control systems.
The most interesting idea is synergy:
spermidine exercise may converge on AMPK–FOXO3, AKT/mTOR, mitochondrial turnover, apoptosis reduction, and autophagic balance.
But caution matters. Most evidence remains preclinical or review-based. Dose, timing, tissue context, fibrosis risk, and long-term safety need human validation.
Take-home:
Healthy muscle aging may require restoring the polyamine–autophagy–mitochondria network, not simply stimulating anabolism.
DOI: 10.1016/j.mad.2026.112188